MEMBRANE TACK

K981459 · Biomet, Inc. · DZL · Jul 14, 1998 · Dental

Device Facts

Record IDK981459
Device NameMEMBRANE TACK
ApplicantBiomet, Inc.
Product CodeDZL · Dental
Decision DateJul 14, 1998
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 872.4880
Device ClassClass 2
AttributesTherapeutic

Intended Use

The Membrane Tack is indicated for use as a means of membrane fixation in Guided Bone Regeneration (GBR) procedures.

Device Story

Membrane Tack is a bioresorbable fixation device for stabilizing barrier membranes during oral/maxillofacial Guided Bone Regeneration (GBR) or Guided Tissue Regeneration (GTR) procedures. Fabricated from LactoSorb, a synthetic polyester copolymer of lactic and glycolic acids; device provides mechanical fixation for resorbable and nonresorbable membranes. Used by oral/maxillofacial surgeons in clinical settings. Device maintains strength for 6-8 weeks post-implantation; undergoes in vivo hydrolysis to lactic and glycolic acids, which are metabolized by the body; complete resorption occurs by 12 months. Benefits include secure membrane stabilization without the need for permanent hardware removal.

Clinical Evidence

No clinical data provided. Safety and effectiveness are supported by biocompatibility data from animal studies and historical clinical use of LactoSorb polymers in craniomaxillofacial reconstructive procedures.

Technological Characteristics

Material: LactoSorb (synthetic polyester copolymer of lactic and glycolic acids). Principle: Mechanical fixation via bioresorbable tack. Degradation: Hydrolysis to lactic and glycolic acids; strength maintained 6-8 weeks; complete resorption by 12 months. Biocompatible in soft and bone tissue.

Indications for Use

Indicated for membrane fixation in Guided Bone Regeneration (GBR) procedures in patients requiring surgical stabilization of barrier membranes.

Regulatory Classification

Identification

An intraosseous fixation screw or wire is a metal device intended to be inserted into fractured jaw bone segments to prevent their movement.

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ ## JUL 1 4 1998 Image /page/0/Picture/1 description: The image shows a handwritten string of characters. The characters appear to be a combination of letters and numbers. The string reads 'ka8M39'. ## 510(k) Summary of Safety and Effectiveness Biomet, Inc. Submitter: P.O. Box 587 Airport Industrial Park 46581-0587 Warsaw, IN Mary L. Verstynen Contact Person: 76DZL Product Code: Membrane Tack Device Name: The Membrane Tack is a barrier membrane fixation tack used in oral/maxillofacial surgical procedures for stabilizing membranes in Guided Bone Regeneration (GBR) or Guided Tissue Regeneration (GBR) procedures or other clinical situations that require membrane use/fixation. The Membrane Tack is used to fixate commercially available resorbable and nonresorbable barrier membranes. The Membrane Tacks are made of LactoSorb® which are composed of bioresorbable and biocompatible polymers that have been used in surgical procedures for years. LactoSorb® resorbable copolymer is a synthetic polyester derived from lactic and Polylactic/polyglycolic acid copolymer glycolic acids. degrades and resorbs IN VIVO by hydrolysis to lactic and glycolic acids which are then metabolized by the body. In animal studies LactoSorb® has been found to be biocompatible in both soft tissue and bone tissue. LactoSorb® devices have been marketed for over two years for use in trauma and reconstructive procedures in the craniomaxillofacial skeleton and have been found to be both safe and effective. The Membrane Tack is substantially equivalent to a marketed bioresorbable membrane tack. It will maintain its strength for 6-8 weeks and completely resorbs by 12 months. {1}------------------------------------------------ Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, with flowing lines representing hair or movement. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 JUL 1 4 1998 Ms. Mary Verstynen Clinical Research Manager Biomet, Incorporated Airport Industrial Park P.O. Box 587 Warsaw, Indiana 46581-0587 K981459 Re : Membrane Tack Trade Name: Requlatory Class: II Product Code: DZL Dated: April 22, 1998 April 23, 1998 Received: Dear Ms. Verstynen: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major requlations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. ದ substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory In addition, FDA may publish further announcements action. concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 {2}------------------------------------------------ Page 2 - Ms. Verstynen through 542 of the Act for devices under the Electronic Chrough 542 OF the not is not is on other Federal laws or requlations. This letter will allow you to begin marketing your device as Inis recei will area for your market notification. The FDA described in your siet., p="ivalence of your device to a legally marketed predicate device results in a classification for your marketed predicate actros your device to proceed to the market. If you desire specific advice for your device on our labeling II you debite bpoories and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Victo diagnobere actroob// place of additionally, for questions on comprimeet at (302) advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). "Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html". Sincerely yours, Timothy A. Ulatowski Director Director Division of Dental, Infection Control, and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ ਦਾ Page of ਹ 1981459 510(k) NUMBER (IF KNOWN) : Membrane Tacks DEVICE NAME: INDICATIONS FOR USE: The Membrane Tack is indicated for use as a means of membrane fixation in Guided Bone Regeneration (GBR) procedures. (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANCTHER PAGE IF NEEDED.) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use (Per 21 CFR 801 109) ﻬﻢ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟ OR Over - The - Counter - Use (Optional Format 1-2-96) (Division Sign-Off) Division of Dental, Infection Control, and General Hospital Devices 510(k) Number
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%